Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Receivables (2016 - 2017)

Historic Receivables for Soleno Therapeutics (SLNO) over the last 6 years, with Q4 2018 value amounting to $64000.0.

  • Soleno Therapeutics' Receivables changed N/A to $64000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $64000.0, marking a year-over-year change of. This contributed to the annual value of $64000.0 for FY2018, which is N/A changed from last year.
  • As of Q4 2018, Soleno Therapeutics' Receivables stood at $64000.0.
  • Soleno Therapeutics' Receivables' 5-year high stood at $288000.0 during Q2 2016, with a 5-year trough of $3000.0 in Q4 2016.
  • Over the past 5 years, Soleno Therapeutics' median Receivables value was $79000.0 (recorded in 2015), while the average stood at $91593.9.
  • In the last 5 years, Soleno Therapeutics' Receivables soared by 230000.0% in 2016 and then tumbled by 9895.83% in 2017.
  • Over the past 5 years, Soleno Therapeutics' Receivables (Quarter) stood at $37000.0 in 2014, then skyrocketed by 321.96% to $156127.0 in 2015, then crashed by 98.08% to $3000.0 in 2016, then changed by 0.0% to $3000.0 in 2017, then skyrocketed by 2033.33% to $64000.0 in 2018.
  • Its Receivables was $64000.0 in Q4 2018, compared to $3000.0 in Q2 2017 and $110000.0 in Q1 2017.